# SEATTLE INST FOR BIOMEDICAL/CLINICAL RES: Targeting MSUT2 with small molecules to ameliorate pathological tau

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | SEATTLE INST FOR BIOMEDICAL/CLINICAL RES |
| Location | SEATTLE, WA |
| Project | Targeting MSUT2 with small molecules to ameliorate pathological tau |
| Project number | 4R01AG078335-02 |
| Mechanism | R01 |
| Institute | National Institute on Aging |
| Award | $688,382 |
| Awarded | 2026-09-16 |
| Project period | 2023-09-01 to 2028-08-31 |
| UEI | DRRKVZVXSND3 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11463459). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.